Skip to main content

Evogene Ltd.

EVGN
Exchange
Nasdaq
Industry
Agricultural Chemicals
SEC CIK
0001574565

In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.

Holders of 5% or more of EVGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evogene Ltd., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of EVGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
L.I.A. Pure Capital Ltd13D/A19.35%3.06M shares0.00 ppfrom 19.35%Jul 10, 20267 filingsSep 11, 2026SEC
Recanati Leon13D/A8.60%1.35M shares0.00 ppfrom 8.60%Aug 11, 20263 filingsSep 11, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

21 Schedule 13D and 13G filings on Evogene Ltd., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on EVGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 11, 20266:31 AM ETL.I.A. Pure Capital Ltdand 3 others13D/A19.35%3.06M shares0.00 ppfrom 19.35%Sep 8, 2026SEC
Sep 11, 20266:01 AM ETRecanati Leon13D/A8.60%1.35M shares0.00 ppfrom 8.60%Aug 4, 2026SEC
Aug 28, 20269:20 AM ETL.I.A. Pure Capital Ltdand 3 others13D/A19.35%3.06M shares0.00 ppfrom 19.35%Aug 28, 2026SEC
Aug 14, 202610:12 AM ETArmistice Capital, LLCand 1 other13G/A4.99%713.5K shares−5.00 ppfrom 9.99%Below 5%Jun 30, 2026SEC
Aug 13, 20262:39 PM ETL.I.A. Pure Capital Ltdand 3 others13D/A19.35%3.06M shares+3.37 ppfrom 15.98%Aug 10, 2026SEC
Aug 13, 20267:06 AM ETRecanati Leon13D/A8.60%1.35M shares+2.90 ppfrom 5.70%Aug 11, 2026SEC
Aug 11, 20268:00 AM ETRecanati Leon13D5.70%894.8K sharesNewAug 4, 2026SEC
Aug 7, 20264:05 PM ETL.I.A. Pure Capital Ltdand 3 others13D/A15.98%2.52M shares−1.43 ppfrom 17.41%Aug 6, 2026SEC
Jul 27, 20267:22 AM ETL.I.A. Pure Capital Ltdand 3 others13D/A17.41%2.31M shares+0.60 ppfrom 16.81%Jul 26, 2026SEC
Jul 20, 20263:46 PM ETL.I.A. Pure Capital Ltdand 3 others13D/A16.81%2.23M shares+4.20 ppfrom 12.61%Jul 16, 2026SEC
Jul 10, 20269:27 AM ETL.I.A. Pure Capital Ltdand 3 others13D12.61%1.53M sharesNewJul 10, 2026SEC
May 15, 202611:17 AM ETArmistice Capital, LLCand 1 other13G9.99%1.10M sharesNewMar 31, 2026SEC
Oct 15, 2024Silverarc Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2024Silverarc Capital Management, LLC13GOld format–New–SEC
Feb 11, 2022Macquarie Group Ltd13G/AOld format–––SEC
Feb 9, 2022ARK Investment Management LLCSuperinvestorARK Invest13G/AOld format–––SEC
Feb 16, 2021ARK Investment Management LLCSuperinvestorARK Invest13G/AOld format–––SEC
Feb 12, 2021Waddell & Reed Financial Inc13G/AOld format–––SEC
Feb 12, 2021Senvest Management, LLC13G/AOld format–––SEC
Feb 8, 20216:16 AM ETUBS Group AG13G/AOld format–––SEC
Jan 21, 2021Alpha Capital Anstalt13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Evogene Ltd. shares.

No Form 144 notices for Evogene Ltd. are on file.